Safety/Efficacy of Balicatib (AAE581) in Adults With Osteoarthritis of the Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

223

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

July 31, 2006

Conditions
Knee Osteoarthritis
Interventions
DRUG

balicatib (AAE581)

Trial Locations (2)

36207

Pinnacle Research Group, Anniston

Unknown

Novartis, Nuremberg

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY

NCT00371670 - Safety/Efficacy of Balicatib (AAE581) in Adults With Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter